Comparative Effects of Flurbiprofen and Benzydamine on COX-2/PGE2 and Inflammatory Cytokine Release in Polyinosinic:polycytidylic Acid-Stimulated Human Tonsil and Bronchial Epithelial Cells
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27177705 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Emmanuel Mfotie Njoya und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield HD1 3DH, UK. Hauptthemen laut MEDLINE: Dinoprostone, Cyclooxygenase 2, Flurbiprofen, Epithelial Cells. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Reckitt Benckiser Health Limited.
Abstract (Originalsprache)
Topical non-steroidal anti-inflammatory drugs (NSAIDs) such as flurbiprofen and benzydamine may be used for the symptomatic relief of pharyngitis, triggered by infections. The onset and spectrum of anti-inflammatory activity of both drugs were compared in human tonsil (HTEpiC) and bronchial epithelial (BEAS-2B) cells stimulated with poly I:C against key inflammatory mediators. Cells were stimulated with poly I:C for 24 h and treated with flurbiprofen or benzydamine for 20 s, 2 min and 5 min. Production of prostaglandin E2 (PGE2), tumour necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), interleukin-1 beta (IL-1β), interleukin-8 (IL-8), interleukin-18 (IL-18), monocyte chemotactic protein-3 (MCP-3) and C-X-C motif chemokine ligand 10 (CXCL10), as well as cyclooxygenase-2 (COX-2) protein expression, was evaluated. Flurbiprofen significantly (p < 0.05) reduced PGE2 production and COX-2 expression in both cell types within 20 s of treatment and maintained these effects at 2 and 5 min. However, benzydamine produced delayed, inconsistent inhibition. Although both drugs reduced poly I:C induced IL-6, IL-1β, IL-8 and IL-18 production, the magnitude and onset were greater with flurbiprofen. Flurbiprofen also reduced MCP-3 and CXCL10 in both cell types, alongside significant inhibition of caspase-1 activity. Benzydamine showed limited or no effect and less inhibition of caspase-1. With rapid suppression of the COX-2/PGE2 pathway, rapid onset and a broad inhibition spectrum, flurbiprofen more comprehensively modulates inflammatory processes in epithelial respiratory models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield HD1 3DH, UK.
- Reckitt Benckiser Health Limited, Dansom Lane, Hull HU8 7DS, UK.
ORCID-Profile: Emmanuel Mfotie Njoya, Thomas Hallett, Olumayokun A Olajide
Förderung
- Reckitt Benckiser Health Limited
Zitieren
APA
Mfotie Njoya, E., Spears, M., Hallett, T., Peters, P., Burke, F., & Olajide, O. A. (2026). Comparative Effects of Flurbiprofen and Benzydamine on COX-2/PGE2 and Inflammatory Cytokine Release in Polyinosinic:polycytidylic Acid-Stimulated Human Tonsil and Bronchial Epithelial Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177705
Vancouver
Mfotie Njoya E, Spears M, Hallett T, Peters P, Burke F, Olajide OA. Comparative Effects of Flurbiprofen and Benzydamine on COX-2/PGE2 and Inflammatory Cytokine Release in Polyinosinic:polycytidylic Acid-Stimulated Human Tonsil and Bronchial Epithelial Cells. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177705
BibTeX
@article{MfotieNjoya2026,
author = {Mfotie Njoya, Emmanuel and Spears, Maria and Hallett, Thomas and Peters, Philippa and Burke, Fiona and Olajide, Olumayokun A},
title = {Comparative Effects of Flurbiprofen and Benzydamine on COX-2/PGE2 and Inflammatory Cytokine Release in Polyinosinic:polycytidylic Acid-Stimulated Human Tonsil and Bronchial Epithelial Cells},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27177705}
}
EUVIMED